IGM Biosciences, Inc. (IGMS) Dividend History

IGM Biosciences, Inc. is a biotechnology company focused on developing innovative immunotherapy and biologic treatments using its proprietary Natural-Killer (NK) cell engager technology. The company aims to create targeted therapies for cancer and other diseases by designing proteins that can precisely direct immune cells to eliminate harmful cells. Headquartered in San Diego, California, IGM Biosciences focuses on advancing next-generation treatments with a focus on safety and efficacy.

325 E Middlefield Road, Mountain View, CA, 94043
Phone: 650-965-7873
Website: https://www.igmbio.com

Dividend History

IGM Biosciences, Inc. currently does not pay dividends

Company News

IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

IGM Biosciences is discontinuing the development of its autoimmune disease drug candidates imvotamab and IGM-2644 due to insufficient efficacy. The company is also reducing its workforce by 73% and has $183.8 million in cash and investments as of December 31, 2024.

GlobeNewswire Inc.
IGM Biosciences to Present at Three Upcoming Investor Conferences

IGM Biosciences, a clinical-stage biotechnology company, announced that it will present at three upcoming investor conferences in November 2024.

GlobeNewswire Inc.
Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move

Small-cap stocks have surged in anticipation of the Federal Reserve's interest rate cut, outperforming the S&P 500 Index. Investors believe that lower borrowing costs will benefit small-cap companies, especially those with higher debt levels.

Benzinga

Featured Companies: APLT SPY VB
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns - Benzinga

The Russell 2000 index of small caps surged over 6% this week, its best performance since October 2023, reaching 31-month highs. However, an analyst warns that the outlook is 'clouded by the Fed's concerns over the labor market', suggesting that rate cuts may not necessarily shield the economically sensitive index from a broader economic slowdown.

Benzinga

Featured Companies: EVGO
IGM Biosciences to Present at the Jefferies Healthcare Conference

MOUNTAIN VIEW, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 5, 2024, at 2:30 p.m. EDT in New York.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 16:13:47 UTC